Novartis halts distribution of its Zantac versions amid probe into impurities
Drug maker halts distribution of its versions of the drug commonly known as Zantac in all its markets, including Canada and the U.S., after contaminants were found in the heartburn drug.
Aucun commentaire:
Enregistrer un commentaire